Literature DB >> 30058057

Inflammation and Metabolic Complications in HIV.

Kassem Bourgi1, Celestine Wanjalla1, John R Koethe2.   

Abstract

PURPOSE OF REVIEW: We aim to provide an in-depth review of recent literature highlighting the role of inflammation involving the adipose tissue, liver, skeletal muscles, and gastrointestinal tract in the development of metabolic complications among persons living with HIV (PLWH). RECENT
FINDINGS: Recent studies in PLWH have demonstrated a significant association between circulating inflammatory markers and development of insulin resistance and metabolic complications. In adipose tissue, pro-inflammatory cytokine expression inhibits adipocyte insulin signaling, which alters lipid and glucose homeostasis. Increased lipolysis and lipogenesis elevate levels of circulating free fatty acids and promote ectopic fat deposition in liver and skeletal muscles. This leads to lipotoxicity characterized by a pro-inflammatory response with worsening insulin resistance. Finally, HIV is associated with gastrointestinal tract inflammation and changes in the gut microbiome resulting in reduced diversity, which is an additional risk factor for diabetes. Metabolic complications in PLWH are in part due to chronic, multisite tissue inflammation resulting in dysregulation of glucose and lipid trafficking, utilization, and storage.

Entities:  

Keywords:  HIV; Inflammation; Metabolic complications; Persons living with HIV

Mesh:

Substances:

Year:  2018        PMID: 30058057     DOI: 10.1007/s11904-018-0411-2

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  177 in total

1.  Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy.

Authors:  Claude Béténé A Dooko; Stephane De Wit; Jacqueline Neuhaus; Adrian Palfreeman; Rosalie Pepe; James S Pankow; James D Neaton
Journal:  J Acquir Immune Defic Syndr       Date:  2014-12-15       Impact factor: 3.731

2.  Characterization of two F4/80-positive Kupffer cell subsets by their function and phenotype in mice.

Authors:  Manabu Kinoshita; Takefumi Uchida; Atsushi Sato; Masahiro Nakashima; Hiroyuki Nakashima; Satoshi Shono; Yoshiko Habu; Hiromi Miyazaki; Sadayuki Hiroi; Shuhji Seki
Journal:  J Hepatol       Date:  2010-07-14       Impact factor: 25.083

3.  The prevalence of lipodystrophy in an ambulant HIV-infected population: it all depends on the definition.

Authors:  V M Carter; J F Hoy; M Bailey; P G Colman; I Nyulasi; A M Mijch
Journal:  HIV Med       Date:  2001-07       Impact factor: 3.180

4.  M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.

Authors:  Jinghong Wan; Merieme Benkdane; Fatima Teixeira-Clerc; Stéphanie Bonnafous; Alexandre Louvet; Fouad Lafdil; Françoise Pecker; Albert Tran; Philippe Gual; Ariane Mallat; Sophie Lotersztajn; Catherine Pavoine
Journal:  Hepatology       Date:  2013-11-20       Impact factor: 17.425

5.  Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial.

Authors:  Temitope Foster; Matthew J Budoff; Sammy Saab; Naser Ahmadi; Craig Gordon; Alan D Guerci
Journal:  Am J Gastroenterol       Date:  2010-09-14       Impact factor: 10.864

6.  Molecular characterization of stool microbiota in HIV-infected subjects by panbacterial and order-level 16S ribosomal DNA (rDNA) quantification and correlations with immune activation.

Authors:  Collin L Ellis; Zhong-Min Ma; Surinder K Mann; Chin-Shang Li; Jian Wu; Thomas H Knight; Tammy Yotter; Timothy L Hayes; Archana H Maniar; Paolo V Troia-Cancio; Heather A Overman; Natalie J Torok; Anthony Albanese; John C Rutledge; Christopher J Miller; Richard B Pollard; David M Asmuth
Journal:  J Acquir Immune Defic Syndr       Date:  2011-08-15       Impact factor: 3.731

7.  CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity.

Authors:  Satoshi Nishimura; Ichiro Manabe; Mika Nagasaki; Koji Eto; Hiroshi Yamashita; Mitsuru Ohsugi; Makoto Otsu; Kazuo Hara; Kohjiro Ueki; Seiryo Sugiura; Kotaro Yoshimura; Takashi Kadowaki; Ryozo Nagai
Journal:  Nat Med       Date:  2009-07-26       Impact factor: 53.440

8.  Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study.

Authors:  Enos Bernasconi; Karim Boubaker; Cornelia Junghans; Markus Flepp; Hans-Jakob Furrer; Alexander Haensel; Bernard Hirschel; Katia Boggian; Jean-Philippe Chave; Milos Opravil; Rainer Weber; Martin Rickenbach; Amalio Telenti
Journal:  J Acquir Immune Defic Syndr       Date:  2002-09-01       Impact factor: 3.731

9.  Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.

Authors:  Denise Kelly; Jamie I Campbell; Timothy P King; George Grant; Emmelie A Jansson; Alistair G P Coutts; Sven Pettersson; Shaun Conway
Journal:  Nat Immunol       Date:  2003-12-21       Impact factor: 25.606

10.  Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.

Authors:  Julian Falutz; Diane Potvin; Jean-Claude Mamputu; Hani Assaad; Monika Zoltowska; Sophie-Elise Michaud; Daniel Berger; Michael Somero; Graeme Moyle; Stephen Brown; Claudia Martorell; Ralph Turner; Steven Grinspoon
Journal:  J Acquir Immune Defic Syndr       Date:  2010-03       Impact factor: 3.731

View more
  17 in total

1.  Cumulative HIV Viremia Copy-Years and Hypertension in People Living with HIV.

Authors:  Yunan Xu; Xinguang Chen; Akemi Wijayabahu; Zhi Zhou; Bin Yu; Emma C Spencer; Robert L Cook
Journal:  Curr HIV Res       Date:  2020       Impact factor: 1.581

2.  Spectrum of Dyslipidemias in Treatment-Naïve Human Immunodeficiency Virus-Infected Patients Presenting to an HIV Clinic of a Tertiary Care Hospital.

Authors:  Sadaf Iqbal; Sadia Salman; Mehwish Akhtar; Amanullah Bhalli; Javeid Iqbal; Ismat Ullah
Journal:  Cureus       Date:  2022-02-07

3.  Gut Dysfunction Markers Are Associated With Body Composition in Youth Living With Perinatally Acquired Human Immunodeficiency Virus.

Authors:  Sahera Dirajlal-Fargo; Denise L Jacobson; Wendy Yu; Ayesha Mirza; Mitchell E Geffner; Jennifer Jao; Grace A McComsey
Journal:  Clin Infect Dis       Date:  2022-09-29       Impact factor: 20.999

4.  Low expression of HIV genes in podocytes accelerates the progression of diabetic kidney disease in mice.

Authors:  Jie Feng; Li Bao; Xuan Wang; Huilin Li; Yuqiang Chen; Wenzhen Xiao; Zhengzhe Li; Liyi Xie; Wanhong Lu; Hongli Jiang; Kyung Lee; John Cijiang He
Journal:  Kidney Int       Date:  2020-12-22       Impact factor: 10.612

5.  Network pharmacology integrated with experimental validation revealed the anti-inflammatory effects of Andrographis paniculata.

Authors:  Naiqiang Zhu; Jingyi Hou; Ning Yang
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

Review 6.  Coronary Artery Disease Manifestations in HIV: What, How, and Why.

Authors:  Arjun Sinha; Matthew J Feinstein
Journal:  Can J Cardiol       Date:  2018-12-04       Impact factor: 6.614

7.  Heightened levels of plasma growth differentiation factor 15 in men living with HIV.

Authors:  Neeti Agarwal; Claudia E Ramirez Bustamante; Huaizhu Wu; Reina Armamento-Villareal; Jordan E Lake; Ashok Balasubramanyam; Sean M Hartig
Journal:  Physiol Rep       Date:  2022-05

8.  Brief Report: Nicotine Metabolism Ratio Increases in HIV-Positive Smokers on Effective Antiretroviral Therapy: A Cohort Study.

Authors:  Cedric H Bien-Gund; Warren Bilker; Robert A Schnoll; Rachel F Tyndale; Joshua I Ho; Remy Bremner; Rebecca L Ashare; Robert Gross
Journal:  J Acquir Immune Defic Syndr       Date:  2022-04-01       Impact factor: 3.771

9.  Prediabetes among HIV-infected individuals receiving antiretroviral therapy: prevalence, diagnostic tests, and associated factors.

Authors:  Angsana Phuphuakrat; Hataikarn Nimitphong; Sirimon Reutrakul; Somnuek Sungkanuparph
Journal:  AIDS Res Ther       Date:  2020-05-24       Impact factor: 2.250

Review 10.  Contribution of Adipose Tissue to the Chronic Immune Activation and Inflammation Associated With HIV Infection and Its Treatment.

Authors:  Christine Bourgeois; Jennifer Gorwood; Anaelle Olivo; Laura Le Pelletier; Jacqueline Capeau; Olivier Lambotte; Véronique Béréziat; Claire Lagathu
Journal:  Front Immunol       Date:  2021-06-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.